1e
19
1
49
2
2
18
1b
1d
18
33
54
1d
2 29
1d
25
Jerome F. Strauss III
88
54
Emeritus Professor of Obstetrics and Gynecology
7
70
Department: Obstetrics and Gynecology
4
1
b
1d
46
Contact information
66
4
3
3
1d
66
Center for Research on Reproduction and Women’s Health
18 Room 1354 BRB II
17 421 Curie Blvd.
3d University of Pennsylvania
Philadelphia, PA 19104
26
18 Room 1354 BRB II
17 421 Curie Blvd.
3d University of Pennsylvania
Philadelphia, PA 19104
2e
Office: 215 898-0147
32 Fax: 215 573-5408
24
8f
32 Fax: 215 573-5408
24
Email:
JFS3@MAIL.MED.UPENN.EDU
12
JFS3@MAIL.MED.UPENN.EDU
18
Publications
23 a
3
2
29
4
b
1f
23 a
13
Education:
21 9 B.A. c
29 Brown University, 1969.
21 9 M.D. c
33 University of Pennsylvania, 1974.
21 a Ph.D. 1e (Molecular Biology) c
33 University of Pennsylvania, 1975.
c
3
3
3
3
8b
Permanent link21 9 B.A. c
29 Brown University, 1969.
21 9 M.D. c
33 University of Pennsylvania, 1974.
21 a Ph.D. 1e (Molecular Biology) c
33 University of Pennsylvania, 1975.
c
2 29
21
1e
1d
24
5e
8
3d Dr. Strauss's laboratory has four primary interests:
8
4e 1. the regulation of steroid hormone synthesis in ovary and placenta;
26 2. polycystic ovary syndrome;
2b 3. the biology of fetal membranes;
32 4. the molecular basis of sperm motility.
8
143 Studies on the control of steroid hormone synthesis are currently focused on the role of proteins that govern the uptake of lipoprotein-carried cholesterol from the circulation and proteins involved in the distribution cholesterol to and within various intracellular organelles. On-going work explores the role and
1ec function of the very low density lipoprotein receptor in placental cholesterol metabolism. Work on intracellular sterol transport addresses sterol efflux from lysosomes and endosomes, sterol transport through the cytoplasm and intra-mitochondrial sterol translocation. Diseases caused by defects in the intracellular trafficking of cholesterol, including Niemann-Pick type C disease and congenital lipoid adrenal hyperplasia, serve as models to explore the roles of specific proteins.
8
c2 The genetic basis of polycystic ovary syndrome and the regulation of thecal androgen synthesis are being investigated as part of the National Cooperative Program in Infertility Research.
8
130 Studies on fetal membranes focus on the activation of collagenolytic enzymes and programmed cell death in the amniotic epithelium at term. The rat amnion and human fetal membranes are under investigation. Genetic factors contributing to premature rupture of the fetal membranes are being sought.
e2 Studies are on-going on the characterization of proteins involved in sperm axonemal function using targeted mutagenesis of genes that are orthologs of Chlamydomonas genes known to be associated with flagellar paralysis.
26 29
27
Description of Research Expertise
28 DESCRIPTION OF RESEARCH8
3d Dr. Strauss's laboratory has four primary interests:
8
4e 1. the regulation of steroid hormone synthesis in ovary and placenta;
26 2. polycystic ovary syndrome;
2b 3. the biology of fetal membranes;
32 4. the molecular basis of sperm motility.
8
143 Studies on the control of steroid hormone synthesis are currently focused on the role of proteins that govern the uptake of lipoprotein-carried cholesterol from the circulation and proteins involved in the distribution cholesterol to and within various intracellular organelles. On-going work explores the role and
1ec function of the very low density lipoprotein receptor in placental cholesterol metabolism. Work on intracellular sterol transport addresses sterol efflux from lysosomes and endosomes, sterol transport through the cytoplasm and intra-mitochondrial sterol translocation. Diseases caused by defects in the intracellular trafficking of cholesterol, including Niemann-Pick type C disease and congenital lipoid adrenal hyperplasia, serve as models to explore the roles of specific proteins.
8
c2 The genetic basis of polycystic ovary syndrome and the regulation of thecal androgen synthesis are being investigated as part of the National Cooperative Program in Infertility Research.
8
130 Studies on fetal membranes focus on the activation of collagenolytic enzymes and programmed cell death in the amniotic epithelium at term. The rat amnion and human fetal membranes are under investigation. Genetic factors contributing to premature rupture of the fetal membranes are being sought.
e2 Studies are on-going on the characterization of proteins involved in sperm axonemal function using targeted mutagenesis of genes that are orthologs of Chlamydomonas genes known to be associated with flagellar paralysis.
26 29
23
136 Arechavaleta-Velasco, F., Koi, H., Strauss III, J.F., Parry, S.: Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? Journal of Reproductive Immunology 55: 113-121, 2002.
df Parry, S., Strauss III, J.F.: Placental protein hormones. Gynecology & Obstetrics. J.J. Sciarra (eds.). Lippincott Williams & Wilkins, in press 2002.
118 Christenson, L.K., Strauss III, J.F.: Cholesterol metabolism in steroidogenic tissues. Genetics of Steroid Biosynthesis and Function. I. Mason (eds.). Taylor & Francis, London and New York, 5: 115-144, 2002.
d9 Strauss III, J.F.: Steroidogenic acute regulatory protein Wiley Encyclopedia of Molecular Medicine. John Wiley & Sons, Inc. 5: 3014-3017, 2002.
111 Fauser, B.C.J.M., Bouchard, P., Hsueh, A.J.W., Rutherford, A.J., Simpson, J.L., Strauss III, J.F.: Reproductive Medicine: Molecular, Cellular and Genetic Fundamentals. Parthenon Press, In press, 2002.
148 Fujimoto, T., Savani, R., Watari, M., Day, A.J., Strauss III, J.F.: Induction of the hyaluronic acid-binding protein TSG-6 in cervical smooth muscle cells by tumor necrosis factor a and prostaglandin E2. American Journal of Pathology 160: 1495-1502, 2002.
1af Fujimoto, T., Parry, S., Urbanek, M., Sammel, M., Macones, G., Kuivaniemi, H., Romero, R., Strauss III, J.F.: A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. Journal of Biological Chemistry 277: 6296-6302, 2002 Notes:
178 Ferrand, P.E., Parry, S., Sammel, M., Macones, G.A., Kuivaniemi, H., Romero, R., Strauss III, J.F.: A polymorphism in the matrix matalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Molecular Human Reproduction 8: 494-501, 2002.
15a Yamamoto, N., Christenson, L.K., McAllister, J.M., Strauss III, J.F.: Growth differential factor-9 inhibits 3’5’-Adenosine monophosphate-stimulated steroidogenesis in human granulose and theca cells. Journal of Clinical Endocrinology and Metabolism 87: 2849-2856, 2002.
2c
7
1d
1f
Selected Publications
ea Wood, J.R., Strauss III, J.F.: Multiple signal transduction pathways regulate ovarian steroidogenesis. Reviews in Endocrine & Metabolic Disorders 3: 33-46, 2002.136 Arechavaleta-Velasco, F., Koi, H., Strauss III, J.F., Parry, S.: Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? Journal of Reproductive Immunology 55: 113-121, 2002.
df Parry, S., Strauss III, J.F.: Placental protein hormones. Gynecology & Obstetrics. J.J. Sciarra (eds.). Lippincott Williams & Wilkins, in press 2002.
118 Christenson, L.K., Strauss III, J.F.: Cholesterol metabolism in steroidogenic tissues. Genetics of Steroid Biosynthesis and Function. I. Mason (eds.). Taylor & Francis, London and New York, 5: 115-144, 2002.
d9 Strauss III, J.F.: Steroidogenic acute regulatory protein Wiley Encyclopedia of Molecular Medicine. John Wiley & Sons, Inc. 5: 3014-3017, 2002.
111 Fauser, B.C.J.M., Bouchard, P., Hsueh, A.J.W., Rutherford, A.J., Simpson, J.L., Strauss III, J.F.: Reproductive Medicine: Molecular, Cellular and Genetic Fundamentals. Parthenon Press, In press, 2002.
148 Fujimoto, T., Savani, R., Watari, M., Day, A.J., Strauss III, J.F.: Induction of the hyaluronic acid-binding protein TSG-6 in cervical smooth muscle cells by tumor necrosis factor a and prostaglandin E2. American Journal of Pathology 160: 1495-1502, 2002.
1af Fujimoto, T., Parry, S., Urbanek, M., Sammel, M., Macones, G., Kuivaniemi, H., Romero, R., Strauss III, J.F.: A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. Journal of Biological Chemistry 277: 6296-6302, 2002 Notes:
178 Ferrand, P.E., Parry, S., Sammel, M., Macones, G.A., Kuivaniemi, H., Romero, R., Strauss III, J.F.: A polymorphism in the matrix matalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Molecular Human Reproduction 8: 494-501, 2002.
15a Yamamoto, N., Christenson, L.K., McAllister, J.M., Strauss III, J.F.: Growth differential factor-9 inhibits 3’5’-Adenosine monophosphate-stimulated steroidogenesis in human granulose and theca cells. Journal of Clinical Endocrinology and Metabolism 87: 2849-2856, 2002.
2c